A detailed history of Disciplined Investors, L.L.C. transactions in Eli Lilly & CO stock. As of the latest transaction made, Disciplined Investors, L.L.C. holds 339 shares of LLY stock, worth $282,553. This represents 0.21% of its overall portfolio holdings.

Number of Shares
339
Previous 293 15.7%
Holding current value
$282,553
Previous $242 Million 9.34%
% of portfolio
0.21%
Previous 0.22%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025

BUY
$713.71 - $898.95 $32,830 - $41,351
46 Added 15.7%
339 $264 Million
Q1 2025

May 12, 2025

BUY
$725.72 - $929.72 $24,674 - $31,610
34 Added 13.13%
293 $242 Million
Q4 2024

Feb 12, 2025

BUY
$727.2 - $932.06 $188,344 - $241,403
259 New
259 $207 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $792B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Disciplined Investors, L.L.C. Portfolio

Follow Disciplined Investors, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Disciplined Investors, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Disciplined Investors, L.L.C. with notifications on news.